Entrada Therapeutics Inc (TRDA)
18.31
+0.85
(+4.87%)
USD |
NASDAQ |
Jan 03, 16:00
18.29
-0.02
(-0.11%)
After-Hours: 20:00
Entrada Therapeutics Research and Development Expense (Annual): 99.88M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Catalyst Pharmaceuticals Inc | 93.15M |
| Vertex Pharmaceuticals Inc | 3.69B |
| Sarepta Therapeutics Inc | 877.39M |
| Regenxbio Inc | 232.27M |
| Edgewise Therapeutics Inc | 90.90M |